These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34681616)

  • 21. ADAR2-dependent GluA2 editing regulates cocaine seeking.
    Schmidt HD; McFarland KN; Darnell SB; Huizenga MN; Sangrey GR; Cha JH; Pierce RC; Sadri-Vakili G
    Mol Psychiatry; 2015 Nov; 20(11):1460-6. PubMed ID: 25349168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
    Sawada J; Yamashita T; Aizawa H; Aburakawa Y; Hasebe N; Kwak S
    Neurosci Res; 2009 Jul; 64(3):251-8. PubMed ID: 19447293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Perampanel for Sporadic Amyotrophic Lateral Sclerosis].
    Aizawa H; Kwak S
    Brain Nerve; 2019 Nov; 71(11):1270-1278. PubMed ID: 31722313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamate receptors: RNA editing and death of motor neurons.
    Kawahara Y; Ito K; Sun H; Aizawa H; Kanazawa I; Kwak S
    Nature; 2004 Feb; 427(6977):801. PubMed ID: 14985749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newly identified ADAR-mediated A-to-I editing positions as a tool for ALS research.
    Kwak S; Nishimoto Y; Yamashita T
    RNA Biol; 2008; 5(4):193-7. PubMed ID: 18971634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2.
    Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S
    Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zebrafish Adar2 Edits the Q/R site of AMPA receptor Subunit gria2α transcript to ensure normal development of nervous system and cranial neural crest cells.
    Li IC; Chen YC; Wang YY; Tzeng BW; Ou CW; Lau YY; Wu KM; Chan TM; Lin WH; Hwang SP; Chow WY
    PLoS One; 2014; 9(5):e97133. PubMed ID: 24818983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice.
    Akamatsu M; Yamashita T; Hirose N; Teramoto S; Kwak S
    Sci Rep; 2016 Jun; 6():28649. PubMed ID: 27350567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Molecular link between inefficient GluA2 RNA editing and TDP-43 pathology in ALS motor neurons].
    Kwak S
    Brain Nerve; 2012 May; 64(5):549-56. PubMed ID: 22570068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosine Deaminase That Acts on RNA 3 (ADAR3) Binding to Glutamate Receptor Subunit B Pre-mRNA Inhibits RNA Editing in Glioblastoma.
    Oakes E; Anderson A; Cohen-Gadol A; Hundley HA
    J Biol Chem; 2017 Mar; 292(10):4326-4335. PubMed ID: 28167531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of editors at the novel A-to-I editing positions.
    Nishimoto Y; Yamashita T; Hideyama T; Tsuji S; Suzuki N; Kwak S
    Neurosci Res; 2008 Jun; 61(2):201-6. PubMed ID: 18407364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenosine-to-inosine RNA editing in neurological development and disease.
    Yang Y; Okada S; Sakurai M
    RNA Biol; 2021 Jul; 18(7):999-1013. PubMed ID: 33393416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippocampus-specific deficiency in RNA editing of GluA2 in Alzheimer's disease.
    Gaisler-Salomon I; Kravitz E; Feiler Y; Safran M; Biegon A; Amariglio N; Rechavi G
    Neurobiol Aging; 2014 Aug; 35(8):1785-91. PubMed ID: 24679603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADAR2 mislocalization and widespread RNA editing aberrations in C9orf72-mediated ALS/FTD.
    Moore S; Alsop E; Lorenzini I; Starr A; Rabichow BE; Mendez E; Levy JL; Burciu C; Reiman R; Chew J; Belzil VV; W Dickson D; Robertson J; Staats KA; Ichida JK; Petrucelli L; Van Keuren-Jensen K; Sattler R
    Acta Neuropathol; 2019 Jul; 138(1):49-65. PubMed ID: 30945056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When Does ALS Start? ADAR2-GluA2 Hypothesis for the Etiology of Sporadic ALS.
    Hideyama T; Kwak S
    Front Mol Neurosci; 2011; 4():33. PubMed ID: 22102833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [ALS and excitatory amino acid].
    Aizawa H; Kwak S
    Brain Nerve; 2007 Oct; 59(10):1117-27. PubMed ID: 17969352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium-permeable AMPA receptors containing Q/R-unedited GluR2 direct human neural progenitor cell differentiation to neurons.
    Whitney NP; Peng H; Erdmann NB; Tian C; Monaghan DT; Zheng JC
    FASEB J; 2008 Aug; 22(8):2888-900. PubMed ID: 18403631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA editing by mammalian ADARs.
    Hogg M; Paro S; Keegan LP; O'Connell MA
    Adv Genet; 2011; 73():87-120. PubMed ID: 21310295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A role of ADAR2 and RNA editing of glutamate receptors in mood disorders and schizophrenia.
    Kubota-Sakashita M; Iwamoto K; Bundo M; Kato T
    Mol Brain; 2014 Jan; 7():5. PubMed ID: 24443933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Calpain plays a crucial role in TDP-43 pathology].
    Yamashita T; Kwak S
    Rinsho Shinkeigaku; 2014; 54(12):1151-4. PubMed ID: 25672733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.